Search Results - "Armenian, S"

Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations by Curigliano, G., Lenihan, D., Fradley, M., Ganatra, S., Barac, A., Blaes, A., Herrmann, J., Porter, C., Lyon, A.R., Lancellotti, P., Patel, A., DeCara, J., Mitchell, J., Harrison, E., Moslehi, J., Witteles, R., Calabro, M.G., Orecchia, R., de Azambuja, E., Zamorano, J.L., Krone, R., Iakobishvili, Z., Carver, J., Armenian, S., Ky, B., Cardinale, D., Cipolla, C.M., Dent, S., Jordan, K.

“…Cancer and cardiovascular (CV) disease are the most prevalent diseases in the developed world. Evidence increasingly shows that these conditions are…”
Get full text

Autologous stem-cell transplantation after second-line brentuximab vedotin in relapsed or refractory Hodgkin lymphoma by Herrera, A.F., Palmer, J., Martin, P., Armenian, S., Tsai, N.-C., Kennedy, N., Sahebi, F., Cao, T., Budde, L.E., Mei, M., Siddiqi, T., Popplewell, L., Rosen, S.T., Kwak, L.W., Nademanee, A., Forman, S.J., Chen, R.

“…We previously demonstrated that brentuximab vedotin (BV) used as second-line therapy in patients with Hodgkin lymphoma is a tolerable and effective bridge to…”
Get full text

Health behaviors and cancer screening practices in long-term survivors of hematopoietic cell transplantation (HCT): a report from the BMT Survivor Study by Armenian, S H, Sun, C-L, Francisco, L, Baker, K S, Weisdorf, D J, Forman, S J, Bhatia, S

“…Patients undergoing hematopoietic cell transplantation (HCT) are at increased risk of chronic health conditions, including second malignant neoplasms and…”
Get full text

Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies by VanderWalde, A M, Sun, C-L, Laddaran, L, Francisco, L, Armenian, S, Berano-Teh, J, Wong, F L, Popplewell, L, Somlo, G, Stein, A S, Nademanee, A, Krishnan, A, Kogut, N, Forman, S J, Bhatia, S

“…The probability of survival is conventionally calculated from autologous hematopoietic cell transplantation (aHCT). Conditional survival takes into account the…”
Get full text

Predictors of discharges against medical advice from a short-term hospital detoxification unit by Armenian, Saro H, Chutuape, Mary Ann, Stitzer, Maxine L

“…The primary goal of this study was to identify factors associated with patients leaving a 3-day hospital detoxification unit against medical advice (AMA)…”
Get full text

Risk Factors for Mortality Resulting From Bloodstream Infections in a Pediatric Intensive Care Unit by Armenian, Saro H, Singh, Jasjit, Arrieta, Antonio C

“…BACKGROUND:Bloodstream infections (BSIs) are prevalent in the critical care setting and have high attributable morbidity and mortality. The purpose of this…”
Get full text

Prognostic impact of resting heart rate on outcomes after allogeneic hematopoietic cell transplantation by Lee, K, Wong, F L, Rhee, J W, Lindenfeld, L, Bosworth, A, Iukuridze, A, He, T, Armenian, S

“…Abstract Funding Acknowledgements Type of funding sources: None. Background Allogeneic hematopoietic cell transplantation (HCT) is an effective treatment for…”
Get full text

Cardiac Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review by Bates, James E., Rancati, Tiziana, Keshavarz, Homa, Gagliardi, Giovanna, Aznar, Marianne C., Howell, Rebecca M., Shrestha, Suman, Moiseenko, Vitali, Yorke, Ellen, Armenian, Saro, Kremer, Leontien, Chen, Ming Hui, van der Pal, Helena J., Cutter, David J., Constine, Louis S., Hodgson, David

“…Radiation therapy (RT) is an essential component in the treatment of many pediatric malignancies. Thoracic RT may expose the heart to radiation dose and…”
Get full text

PO-1171 Ten-year follow-up of tandem autologous transplantation with total marrow irradiation for myeloma by Ladbury, C., Rincon, A., Song, J., Armenian, S., Liu, A., Spielberger, R., Popplewell, L., Sahebi, F., Parker, P., Forman, S., Snyder, D., Dagis, A., Frankel, P., Yang, D., Wong, J., Somlo, G.

Get full text

056 - REDUCING CHEMORADIOTHERAPY AND RADIATION EXPOSURE FROM DIAGNOSTIC IMAGING BY UTILIZING TARGED IMMUNOTHERAPY IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS (CAYA) WITH MATURE LARGE B-CELL LYMPHOMA (RADICAL) by Audino, A., Xavier, A., Hochberg, J., Barth, M., Miles, R., Kahwash, S., Voss, S., Braniecki, S., Moorthy, C., Armenian, S., Ehrhardt, M., Lim, M., Harrison, L., Goldman, S., Cairo, M.

Get full text

015 - REDUCING THE BURDEN OF ONCOLOGY CHEMORADIOTHERAPY AND RADIATION EXPOSURE FROM DIAGNOSTIC IMAGING BY UTILIZING TARGETED IMMUNOTHERAPY IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH LYMPHOMA (RADICAL, HODGKIN LYMPHOMA COHORT by Hochberg, J., Xavier, A., Audino, A., Barth, M., Miles, R., Kahwash, S., Voss, S., Braniecki, S., Moorthy, C., Armenian, S., Ehrhardt, M., Lim, M., Harrison, L., Goldman, S., Cairo, M.

Get full text

REDUCING THE BURDEN OF ONCOLOGY CHEMORADIOTHERAPY AND RADIATION EXPOSURE FROM DIAGNOSTIC IMAGING BY UTILIZING TARGETED IMMUNOTHERAPY IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH LYMPHOMA (RADICAL, HODGKIN LYMPHOMA COHORT by Hochberg, J., Xavier, A., Audino, A., Barth, M., Miles, R., Kahwash, S., Voss, S., Braniecki, S., Moorthy, C., Armenian, S., Ehrhardt, M., Lim, M., Harrison, L., Goldman, S., Cairo, M.

Get full text

REDUCING CHEMORADIOTHERAPY AND RADIATION EXPOSURE FROM DIAGNOSTIC IMAGING BY UTILIZING TARGED IMMUNOTHERAPY IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS (CAYA) WITH MATURE LARGE B-CELL LYMPHOMA (RADICAL) by Audino, A., Xavier, A., Hochberg, J., Barth, M., Miles, R., Kahwash, S., Voss, S., Braniecki, S., Moorthy, C., Armenian, S., Ehrhardt, M., Lim, M., Harrison, L., Goldman, S., Cairo, M.

Get full text

Painless urethral bleeding: an unusual presentation of Von Willebrand disease by Armenian, S., Raffel, J. L., Nugent, D. J., Young, G.

“…Von Willebrand disease (vWD) is the most common bleeding disorder, and usually presents with either easy bruising or mucus membrane bleeding. Many patients are…”
Get full text

Cardiac Disease in Childhood Cancer Survivors Treated with Radiotherapy: Final Results from the PENTEC Group by Bates, J.E., Keshavarz, H., Rancati, T., Gagliardi, G., Aznar, M.C., Moiseenko, V., Yorke, E.D., Armenian, S., Kremer, L., Chen, M.H., van der Pal, H., Cutter, D., Constine, L.S., Hodgson, D.

Get full text

Modeling Radiation Therapy-Related Risk of Heart Failure in Survivors of Pediatric Malignancy: Early Results from the Pediatric Normal Tissue Effects in the Clinic (PENTEC) Group by Bates, J.E., Keshavarz, H., Rancati, T., Yorke, E.D., Gagliardi, G., Aznar, M.C., Moiseenko, V., Armenian, S., Kremer, L., Chen, M.H., Ronckers, C.M., van der Pal, H., Cutter, D., Constine, L.S., Hodgson, D.

Get full text

Predictors of Therapy-Related Myelodysplasia and Acute Myeloid Leukemia (t-MDS/AML) After Autologous Hematopoietic Cell Transplantation (AHCT) for Hematologic Malignancies by Sun, C.-L, Teh, J.B, Tomassian, L, Gyorffy, J, Wang, S, Popplewell, L, Krishnan, A, Nademanee, A, Forman, S, Armenian, S, Bhatia, R, Bhatia, S

Get full text

Cardiovascular disease after hematopoietic cell transplantation--lessons learned by Armenian, Saro H, Bhatia, Smita

Get full text

Incidence and predictors of delayed congestive heart failure (CHF) after hematologic malignancies treated with autologous hematopoietic cell transplantation (aHCT) by Armenian, S., Sun, C., Shannon, T., Shangguan, M., MIlls, G., Francisco, L., Wong, F. L., Forman, S. J., Bhatia, S.

“…Abstract only…”
Get full text

Screening for cardiac dysfunction and cardiovascular risk factors in childhood cancer survivors using the Children's Oncology Group (COG) Long-term Follow-up (LTFU) Guidelines by Armenian, S., Landier, W., Sun, C., Lee, J., Zomorodi, M., Francisco, L., Wilson, K., Bhatia, S.

“…Abstract only…”
Get full text